Document Detail


Case report of embryonal rhabdomyosarcoma of the testis with an 8-year survival.
MedLine Citation:
PMID:  1159930     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The low incidence of embryonal rhabdomyosarcoma prevents any one person or institution from presenting any meaningful data in the form of effective treatment based on clinical experience. We realize that this is an antidotal case but the stakes are high when treating any malignancy of the young. Therefore, we advocate early and aggressive therapy using all modalities of treatments, and cite this case which initially seemed hopeless but to date has all the hallmarks of a cure.
Authors:
M J Jungling; D A Culp
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of urology     Volume:  114     ISSN:  0022-5347     ISO Abbreviation:  J. Urol.     Publication Date:  1975 Aug 
Date Detail:
Created Date:  1975-11-26     Completed Date:  1975-11-26     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0376374     Medline TA:  J Urol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  313-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Antineoplastic Agents / therapeutic use*
Dactinomycin / therapeutic use
Humans
Lung Neoplasms / pathology
Male
Methotrexate / therapeutic use
Neoplasm Metastasis
Prognosis
Remission, Spontaneous
Rhabdomyosarcoma / drug therapy*,  pathology
Testicular Neoplasms / drug therapy*
Vincristine / therapeutic use
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 50-76-0/Dactinomycin; 57-22-7/Vincristine; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hematuria caused by atheromatous embolism: report of a case diagnosed intravitam.
Next Document:  Evaluation of myocardial contractility by the non-invasive method.